Compare · JCI vs MLAB
JCI vs MLAB
Side-by-side comparison of Johnson Controls International plc (JCI) and Mesa Laboratories Inc. (MLAB): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both JCI and MLAB operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- JCI is the larger of the two at $85.91B, about 120.5x MLAB ($712.6M).
- MLAB has been more active in the news (13 items in the past 4 weeks vs 4 for JCI).
- JCI has more recent analyst coverage (25 ratings vs 3 for MLAB).
- Company
- Johnson Controls International plc
- Mesa Laboratories Inc.
- Price
- $141.81-0.85%
- $128.13+3.12%
- Market cap
- $85.91B
- $712.6M
- 1M return
- -1.07%
- -
- 1Y return
- +30.75%
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 4
- 13
- Recent ratings
- 25
- 3
Johnson Controls International plc
Johnson Controls International plc operates as a diversified technology and multi industrial company worldwide. It operates through Building Solutions North America, Building Solutions EMEA/LA, Building Solutions Asia Pacific, and Global Products segments. The company designs, sells, installs, and services heating, ventilating, air conditioning, controls, refrigeration, integrated electronic security, and integrated fire detection and suppression systems for commercial, industrial, retail, small business, institutional, and governmental customers; and energy efficiency solutions and technical services, including inspection, scheduled maintenance, and repair and replacement of mechanical and control systems, as well as data-driven smart building solutions to non-residential building and industrial applications. It also designs and produces heating and air conditioning for residential and commercial applications; and markets products and refrigeration systems to replacement and new construction market; and designs, manufactures, and sells fire protection and security products, including intrusion security, anti-theft devices, and access control and video management systems for commercial, industrial, retail, residential, small business, institutional, and governmental customers. The company was formerly known as Johnson Controls, Inc. and changed its name to Johnson Controls International plc in September 2016. Johnson Controls International plc was founded in 1885 and is headquartered in Cork, Ireland.
Mesa Laboratories Inc.
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment designs, manufactures, and markets quality control hardware and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. This segment's products include dialysate meters and calibration solutions, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company's Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Continuous Monitoring segment designs, develops, and markets systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Latest JCI
- Director Cohade Pierre E sold $487,707 worth of Ordinary Shares (3,300 units at $147.79), decreasing direct ownership by 23% to 10,775 units (SEC Form 4)
- VP & Pres, GP & Solutions Schlitz Lei Zhang sold $3,584,358 worth of Ordinary Shares (23,417 units at $153.07), decreasing direct ownership by 61% to 15,017 units (SEC Form 4)
- EVP and CFO Vandiepenbeeck Marc covered exercise/tax liability with 19,760 units of Ordinary Shares, decreasing direct ownership by 14% to 125,861 units (SEC Form 4)
- VP & Pres, GP & Solutions Schlitz Lei Zhang covered exercise/tax liability with 18,625 units of Ordinary Shares, decreasing direct ownership by 33% to 38,434 units (SEC Form 4)
- SEC Form 10-Q filed by Johnson Controls International plc
- Johnson Controls International plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Johnson Controls Reports Strong Q3 Results; Raises FY26 Guidance
- Johnson Controls introduces Absorption Chiller Reference Design Guide, unlocking up to 97MW of additional AI capacity from on-site power generation
- EVP and CHRO Scalia Christopher M covered exercise/tax liability with 3,901 units of Ordinary Shares, decreasing direct ownership by 14% to 23,878 units (SEC Form 4)
- Johnson Controls Announces Third Quarter 2026 Earnings Conference Call Webcast
Latest MLAB
- Director Capone Mark Christopher converted options into 2,784 shares, increasing direct ownership by 81% to 6,213 units (SEC Form 4)
- Director Alltoft Jennifer Sadie converted options into 2,784 shares, increasing direct ownership by 57% to 7,662 units (SEC Form 4)
- Director Ladiwala Shiraz Shabanali converted options into 3,810 shares, increasing direct ownership by 45% to 12,333 units (SEC Form 4)
- Director Hall Shannon converted options into 2,784 shares, increasing direct ownership by 66% to 6,973 units (SEC Form 4)
- Director Tripeny R Tony converted options into 2,784 shares, increasing direct ownership by 44% to 9,082 units (SEC Form 4)
- Director Sullivan John James converted options into 2,784 shares, increasing direct ownership by 16% to 20,618 units (SEC Form 4)
- Director Sullivan John James sold $800,090 worth of shares (7,093 units at $112.80), decreasing direct ownership by 28% to 17,834 units (SEC Form 4)
- President and CEO Kadia Siddhartha bought $800,090 worth of shares (7,093 units at $112.80) (SEC Form 4)
- Director Tripeny R Tony bought $102,321 worth of shares (900 units at $113.69), increasing direct ownership by 17% to 6,298 units (SEC Form 4)
- SEC Form 10-Q filed by Mesa Laboratories Inc.